HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

YueYue Li Selected Research

Inflammation (Inflammations)

12/2021Inhibition of GPR17 with cangrelor improves cognitive impairment and synaptic deficits induced by Aβ1-42 through Nrf2/HO-1 and NF-κB signaling pathway in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


YueYue Li Research Topics

Disease

4Cognitive Dysfunction
10/2022 - 12/2021
3Neuroinflammatory Diseases
08/2022 - 12/2021
2Alzheimer Disease (Alzheimer's Disease)
10/2022 - 12/2021
1Brain Diseases (Brain Disorder)
12/2021
1Inflammation (Inflammations)
12/2021

Drug/Important Bio-Agent (IBA)

3O-1602 compoundIBA
10/2022 - 01/2022
2Streptozocin (Streptozotocin)FDA Link
08/2022 - 01/2022
2Amyloid beta-PeptidesIBA
08/2022 - 12/2021
2CytokinesIBA
01/2022 - 12/2021
1Amyloid (Amyloid Fibrils)IBA
10/2022
1Peptides (Polypeptides)IBA
10/2022
1LipopolysaccharidesIBA
08/2022
1Malondialdehyde (Propanedial)IBA
01/2022
1Superoxides (Superoxide)IBA
01/2022
1Glutathione (Reduced Glutathione)IBA
01/2022
1CatalaseIBA
01/2022
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
12/2021
1cangrelorIBA
12/2021
1Proteins (Proteins, Gene)FDA Link
12/2021